The new experimental strategy of using humanized antibody against human TF in transgenic mice offers a useful tool for further assessing the anti-TF therapy in preclinical trials for ARDS as well as other diseases related to the function of tissue factor. Here, TF is linked to acute respiratory distress syndrome.